Amir Avan Selected Research

ribosomal protein L1

10/2021

Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amir Avan Research Topics

Disease

131	Neoplasms (Cancer) 08/2022 - 01/2012
47	Colorectal Neoplasms (Colorectal Cancer) 08/2022 - 11/2015
27	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
24	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2012
23	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2015
22	Breast Neoplasms (Breast Cancer) 09/2020 - 05/2015
21	Inflammation (Inflammations) 01/2022 - 09/2017
15	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 04/2016
15	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2020 - 01/2015
14	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2015
13	Carcinogenesis 09/2020 - 01/2016
12	Adenocarcinoma 03/2022 - 01/2012
10	Fibrosis (Cirrhosis) 01/2022 - 01/2019
10	Colonic Neoplasms (Colon Cancer) 10/2021 - 01/2016
9	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2021 - 01/2014
8	Stroke (Strokes) 01/2022 - 01/2017
8	Obesity 01/2022 - 03/2015
8	Colitis 01/2022 - 01/2018
7	Atherosclerosis 01/2021 - 07/2016
5	Ulcerative Colitis 01/2022 - 01/2018
5	Hypertension (High Blood Pressure) 01/2021 - 09/2014
5	Lung Neoplasms (Lung Cancer) 02/2020 - 01/2014
4	Liver Diseases (Liver Disease) 09/2022 - 12/2017
4	Diarrhea 06/2022 - 09/2020
4	Infections 01/2022 - 01/2018
4	Hemorrhage 01/2021 - 10/2018
3	Vomiting 06/2022 - 01/2021
3	Nausea 06/2022 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 03/2022 - 01/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 01/2013
3	Necrosis 01/2021 - 01/2021
3	Fatty Liver 01/2021 - 01/2019
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 09/2018
3	Edema (Dropsy) 01/2020 - 01/2019
3	Mesothelioma 01/2020 - 01/2014
3	Menstruation Disturbances 01/2019 - 12/2017

Drug/Important Bio-Agent (IBA)

49	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2014
35	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2012
17	Fluorouracil (Carac)FDA LinkGeneric 08/2022 - 01/2017
16	CytokinesIBA 01/2022 - 09/2014
15	Gemcitabine FDA Link 01/2022 - 01/2012
13	Pharmaceutical PreparationsIBA 08/2022 - 01/2013
13	Proteins (Proteins, Gene)FDA Link 09/2020 - 02/2016
12	Vitamin D FDA LinkGeneric 01/2021 - 01/2017
11	CateninsIBA 08/2022 - 07/2014
9	Biological ProductsIBA 03/2022 - 01/2016
9	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2020
9	AntioxidantsIBA 10/2021 - 01/2016
9	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 01/2014
9	CurcuminIBA 10/2019 - 01/2017
9	EnzymesIBA 05/2019 - 01/2014
8	LipidsIBA 01/2022 - 01/2015
8	Peptides (Polypeptides)IBA 10/2021 - 01/2018
8	C-Reactive ProteinIBA 01/2021 - 08/2017
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2019
7	CholesterolIBA 06/2021 - 07/2016
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2020 - 01/2017
6	crocinIBA 07/2021 - 12/2017
6	Long Noncoding RNAIBA 11/2019 - 01/2018
6	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2018
6	Triglycerides (Triacylglycerol)IBA 01/2019 - 03/2015
6	CrizotinibIBA 01/2018 - 01/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 08/2015
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 09/2014
5	CollagenIBA 01/2022 - 01/2019
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2018
5	HDL CholesterolIBA 12/2021 - 03/2015
5	Thrombin FDA Link 01/2019 - 03/2017
5	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019 - 01/2018
4	Cyclin D1IBA 08/2022 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 07/2017
4	Angiotensin IIIBA 01/2022 - 01/2020
4	Valsartan (Vals)FDA Link 01/2022 - 01/2021
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 01/2019
4	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2018
4	Oxidants (Oxidizing Agents)IBA 10/2021 - 01/2018
4	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 09/2018
4	Sulfhydryl Compounds (Thiols)IBA 01/2021 - 01/2018
4	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2012
4	Bacteriocins (Lantibiotics)IBA 08/2020 - 11/2019
4	CalciumIBA 06/2020 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 06/2015
4	HDL LipoproteinsIBA 05/2019 - 03/2015
3	Cadherins (E-Cadherin)IBA 08/2022 - 01/2019
3	InterferonsIBA 04/2022 - 01/2016
3	LigandsIBA 03/2022 - 01/2019
3	Losartan (Cozaar)FDA LinkGeneric 01/2022 - 01/2020
3	AngiotensinsIBA 01/2022 - 01/2022
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2022 - 01/2021
3	Therapeutic UsesIBA 08/2021 - 01/2019
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 08/2021 - 09/2020
3	Dextrans (Dextran)FDA Link 08/2021 - 09/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2019
3	Cell Adhesion MoleculesIBA 02/2020 - 01/2019
3	Pemetrexed (MTA)FDA Link 01/2020 - 01/2014
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 01/2019

Therapy/Procedure

51	Therapeutics 01/2022 - 01/2014
23	Drug Therapy (Chemotherapy) 10/2021 - 01/2012
7	Radiotherapy 08/2020 - 01/2017
3	Immunotherapy 04/2020 - 01/2018